- Release Date: 25/07/24 13:04
- Summary: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
- Price Sensitive: Yes
- Download Document 170.67KB
- Forums
- ASX - By Stock
- Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
Ann: Sustained Reduction in Tumour Size Seen In Pancreatic Trial
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.0¢ |
Change
0.005(3.45%) |
Mkt cap ! $41.21M |
Open | High | Low | Value | Volume |
15.5¢ | 16.0¢ | 15.0¢ | $55.88K | 361.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 94946 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 56159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 94946 | 0.150 |
3 | 42061 | 0.145 |
11 | 640690 | 0.140 |
8 | 277010 | 0.135 |
4 | 130715 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 56159 | 1 |
0.165 | 7500 | 2 |
0.175 | 100000 | 1 |
0.180 | 1383867 | 3 |
0.185 | 69568 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
ATX (ASX) Chart |